Image source: The Motley Fool. TechTarget, Inc. (NASDAQ:TTGT) delivered flat full-year revenue but accelerated adjusted EBITDA growth, reflecting significant cost synergies and operational leverage ...

Marvell is positioned to benefit from XPU-attach and optical networking opportunities, with FCF growth expected to exceed 30% ...

Agilent acquires Biocare for $950M to boost pathology/cancer diagnostics and recurring revenue. Click here to read an analysis of A stock now.

Marvell Technology, Inc. (NASDAQ:MRVL) Q4 2026 Earnings Call Transcript March 5, 2026 Marvell Technology, Inc. beats earnings expectations. Reported EPS is $0.8, expectations were $0.792. Operator: ...

Bowman Consulting Group Ltd. (NASDAQ:BWMN) Q4 2025 Earnings Call Transcript March 5, 2026 Operator: Good morning. My name is ...

PACS Group leaders reported a landmark 2025 during the company’s fourth-quarter earnings call Thursday, highlighting a year defined by record financial outcomes.

Telix Pharmaceuticals focuses on radiopharmaceuticals for the diagnosis and treatment of cancer.

Gross Profit -- $18.7 million, representing growth of 20% compared to $15.5 million previously reported. Oxford Collaboration ...

Itron’s fourth quarter results drew a strong positive reaction from the market, as management emphasized robust execution amid a shifting utility landscape. CEO Thomas Deitrich attributed performance ...

Free cash flow conversion is projected at 80% for 2026, a decrease from 2025 levels as the company becomes a full cash taxpayer after exhausting net operating losses (NOLs). Strategic initiatives ...

Despite operating losses, OraSure Technologies Inc (OSUR) showcases strong revenue performance and strategic product expansions for 2026.

Good morning all, and welcome to Lamar's Q4 2025 Earnings Call. We ended 2025 with encouraging sales momentum with both local and national delivering growth in Q4 despite a challenging political comp ...